Publications | NDEWS l National Drug Early Warning System l University of Maryland

DEWS - Central Receiving Facility (CRF) at Gracepoint – Hillsborough County, FloridaWish, E.D., Billing, A.S., Artigiani, E.E, and Hippolyte, T. (2020). Office of National Drug Control Policy. Washington, DC: Executive Office of the President. CDEWS-5-Gracepoint-2020-FinalReport.pdf519.79 KB
Juvenile Assessment Center (JAC) Program - Tampa, FloridaWish, E.D., Billing, A.S., Artigiani, E.E, and Hippolyte, T. (2020). Office of National Drug Control Policy. Washington, DC: Executive Office of the President. CDEWS-5-TampaJAC-2020-FinalReport.pdf385.42 KB
Substance Use Trends in San Francisco Through 2018Phillip O. Coffin MD MIA, Christopher Rowe MPH, and Amanda Bierkamp San-Francisco-Substance-Use-2019-Annual-Report-Trends-Through-2018.pdf1.2 MB
Reducing opioid overdose deaths in Minnesota: Insights from one tribal nationBrenna Greenfield, Erin Russell, Hannah Youngdeer, Melissa Walls, and Clinton Alexander MinnesotaHotSpotReport-December-2019-FINAL.pdf534.79 KB
S. Dakota's 'Meth. We're on it.' campaign confuses but draws attention to growing crisis
NDEWS HotSpot Report Naloxone Substudy: Cleveland, OhioLee Hoffer, Ph.D., MPE, Allison Schlosser, Ph.D., MSW, and Kayla Buckelew NDEWS-Naloxone-Report-Cleveland-FINAL.pdf368.17 KB
NDEWS Naloxone Substudy: Baltimore, Maryland; Characterizing Knowledge, Attitudes, Behaviors, and Practices Related to Bystander NaloxoneAnnabelle M. Belcher, Ph.D., Thomas O. Cole, MA, Alexander Pappas, MD, Raman Sandhu, MD, Rachel Steere, DO, and Zofia Kozak, BS NDEWS-Naloxone-Report-Baltimore-FINAL2.pdf956.5 KB
NDEWS Naloxone Substudy: Worcester, MA; Characterizing Knowledge, Attitudes, Behaviors, and Practices Related to Bystander NaloxoneJeffrey T. Lai, MD, Charlotte Goldfine, MD, Brittany P. Chapman, BSc, Melissa M. Taylor, BA, Rochelle K. Rosen, Ph.D., Stephanie P. Carreiro, MD, and Kavita M. Babu, MD NDEWS-Naloxone-Report-Worcester FINAL.pdf73.33 KB
17 Tramadol Cases Reported to the ToxIC Registry, January 1, 2018–June 30, 2019Meghan Spyres, MD; Paul Wax, MD; Sharan Campleman, PhD; Jeffrey Brent, MD, PhD; Diane Calello, MD American College of Medical Toxicology, Phoenix, AZ ToxIC-Series-Issue-4-FINAL-093019.pdf405.25 KB
Lee Hoffer, Ph.D., MPE, Allison Schlosser, Ph.D., MSW,2 and Kayla Buckelew; NDEWS HotSpot Report - Fentanyl: User Beliefs & Practices - Cleveland, Ohio Cleveland-NDEWS-Hotspot-Final-Report-09-04-19.pdf704.4 KB
The Co-Use of Methamphetamine and Opioids Among Patients in Treatment in Oregon, USA; Andrea M. Lopez, Ph.D., Department of Anthropology, University of Maryland, College ParkThe National Drug Early Warning System Coordinating Center, Center for Substance Abuse Research, University of Maryland, College Park NDEWS-Hotspot-Serenity-Lane-Sept2019-FINAL.pdf615.2 KB
Cao, Y., Stewart, K., Wish, E., Artigiani, E., Sorg, M. (2019). Determining spatial access to opioid use disorder treatment and emergency medical services in New Hampshire. Journal of Substance Abuse Treatment.
A Pilot Study Using Electronic Health Records from Hospital Emergency Departments to Monitor Drug Use Trends in Overdose Patients in the Baltimore Area, January 2016-December 2018Zachary D.W. Dezman, MD, Daniel L. Lemkin, MD, J. Kathleen Tracy, PhD, Eric D. Wish, PhD, Amy Billing, MSSA, Julie Factor, BA, BSN, Ebonie Massey, MA, & E. Erin Artigiani, MA EPIC-EHR-Baltimore_2016-2018.pdf1.9 MB
Using Hospital Electronic Health Records to Monitor Drug Use Trends in Emergency Department Patients at the University of Maryland Prince George’s Hospital CenterBradford Schwartz, MD, Eric D. Wish, PhD, Amy Billing, MSSA, Julie Factor, BA, Ebonie Massey, MA, & E. Erin Artigiani, MA Cerner_Bulletin_May2019.pdf621.93 KB
Billing, A.S., Artigiani, E.E, Hippolyte, T., and Wish, E.D. (2019). Drug Early Warning Signals (DEWS): Serenity Lane - Coburg, Oregon. Office of National Drug Control Policy. Washington, DC: Executive Office of the President. DEWS-Serenity-Lane-March-2019-Final.pdf1.06 MB
Billing, A.S., Artigiani, E.E., Hippolyte, T., and Wish, E.D. (2019). Drug Early Warning Signals (DEWS): Methodology Overview. Office of National Drug Control Policy. Washington, DC: Executive Office of the President. DEWS-Methodology-Overview-March-2019.pdf1.37 MB
ToxIC Brief: Issue 3, Synthetic Cannabinoids Cases Reported to the ToxIC Registry, August 1, 2018–January 31, 2019 Meghan Spyres, MD; Paul Wax, MD; Sharan Campleman, PhD; Jeffrey Brent, MD, PhD; Diane Calello, MD American College of Medical Toxicology, Phoenix, AZ ToxIC-Series-Issue-3-FINAL.pdf302.33 KB
Wish, E.D., Billing, A.S., Artigiani, E.E, and Hippolyte, T. (2019). Drug Early Warning Signals (DEWS): Operation PAR – North Fort Myers, Florida. Office of National Drug Control Policy. Washington, DC: Executive Office of the President. DEWS-Operation-PAR-March-2019-Final.pdf1.02 MB
Using Electronic Health Records to Track Emerging Drug Problems in Baltimore (February 2019)Zachary D.W. Dezman, MD, Daniel L. Lemkin, MD, J. Kathleen Tracy, PhD, Eric D. Wish, PhD, Amy Billing, MSSA, Julie Factor, BA, Ebonie Massey, MA, & E. Erin Artigiani, MA MPower_EpicBulletin_Feb2019_Revised.pdf443.65 KB
Novel Synthetic Opioids Cases Reported to the ToxIC Registry, August–October 2018 Meghan Spyres, MD; Paul Wax, MD; Sharan Campleman, PhD; Jeffrey Brent, MD, PhD; Diane Calello, MD American College of Medical Toxicology, Phoenix, AZ toxic-series-issue-2-final.pdf274.18 KB
The Opioid Crisis Is Becoming A Meth And Cocaine Crisis, by Dan Vergano, BuzzFeed News
Fentanyl Intoxication Deaths Highlighted in All 2018 NDEWS Sentinel Community Site Reports; Four Sites Report Fentanyl in More Than Half of All Drug Deaths ndews-news-issue-7-december-2018.pdf310.77 KB
DOTS Issue 8 - Methamphetamine and New Psychoactive Substances Detected in Specimens from Pretrial Services Agency for the District of Columbia dotsbulletin-issue8-october2018-dcpsa_0.pdf148.3 KB
Evaluation of Nicotine and the Components of e-Liquids Generated from e-Cigarette Aerosols Michelle R. Peace, Haley A. Mulder, Tyson R. Baird, Karen E. Butler, Alaina K. Friedrich, Joseph W. Stone, Joseph B. McGee Turner, Alphonse Poklis, Justin L. Poklis
The unexpected identification of the cannabimimetic, 5F-ADB, and dextromethorphan in commercially available cannabidiol e-liquids; Justin L. Poklis, Haley A. Mulder, Michelle R. Peace